| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/25/1996 | WO1996001813A1 CONFORMATIONALLY RIGID BICYCLIC AND ADAMANTANE DERIVATIVES USEFUL AS α2-ADRENERGIC BLOCKING AGENTS |
| 01/25/1996 | WO1996001655A1 Cascade-polymer complexes and methods of producing the same |
| 01/25/1996 | WO1996001652A1 Aqueous risperidone formulations |
| 01/25/1996 | WO1996001645A1 Use of muramyl peptide compounds |
| 01/25/1996 | WO1996001640A1 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 01/25/1996 | WO1996001639A1 Synthetic glycoamines that promote or inhibit cell adhesion |
| 01/25/1996 | WO1996001637A1 New pharmaceutical preparation for pain management |
| 01/25/1996 | WO1996001636A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | WO1996001635A1 Controlling bone resorption with pyrroloquinoline quinone (pqq) and related compounds |
| 01/25/1996 | WO1996001634A1 Long-acting oxytetracycline composition |
| 01/25/1996 | WO1996001633A1 New formulation for the topical treatment of psoriasis |
| 01/25/1996 | WO1996001632A1 Method and compound for the treatment of hair loss |
| 01/25/1996 | WO1996001631A1 Novel combination product comprising capripramine and a neuroleptic |
| 01/25/1996 | WO1996001629A1 Hydromorphone therapy |
| 01/25/1996 | WO1996001628A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |
| 01/25/1996 | WO1996001627A1 Use of swinholide a for severing and depolymerizing actin |
| 01/25/1996 | WO1996001626A1 Transdermal drug delivery system |
| 01/25/1996 | WO1996001624A1 Multiple unit pharmaceutical preparation containing proton pump inhibitor |
| 01/25/1996 | WO1996001623A1 Multiple unit tableted dosage form i |
| 01/25/1996 | WO1996001622A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
| 01/25/1996 | WO1996001621A1 New beads for controlled release and a pharmaceutical preparation containing the same |
| 01/25/1996 | WO1996001618A1 Dermatologic preparation |
| 01/25/1996 | WO1996001617A1 Nucleic acid filters |
| 01/25/1996 | WO1996001614A2 Rna component of telomerase |
| 01/25/1996 | WO1996001613A2 Alcoholic moisturizing after shave lotion |
| 01/25/1996 | WO1996001561A1 Method of regulating immune function |
| 01/25/1996 | WO1996001560A1 Two-and three-component fungicidal mixtures |
| 01/25/1996 | WO1996001558A1 Anandamide analogue compositions and method of treating intraocular hypertention using same |
| 01/25/1996 | DE4426709A1 Steroidale Sexualhormone enthaltende feste Arzneiformen Sex steroid-containing solid dosage forms |
| 01/25/1996 | DE4425950A1 Treating glaucoma or diabetic retinopathy |
| 01/25/1996 | DE19526187A1 7-Diazo-beta-lactamderivate und Verfahren zu deren Herstellung 7-diazo-beta-lactam derivatives and process for their preparation |
| 01/25/1996 | CA2194872A1 Pyridopyrazine derivatives |
| 01/25/1996 | CA2194773A1 Method and compound for the treatment of hair loss |
| 01/25/1996 | CA2194768A1 Human kappa opioid receptor, nucleic acids and uses thereof |
| 01/25/1996 | CA2194702A1 Conformationally rigid bicyclic and adamantane derivatives useful as .alpha.2-adrenergic blocking agents |
| 01/25/1996 | CA2194694A1 Pyrido[3,2,1-i,j][3,1]benzoxazine derivatives |
| 01/25/1996 | CA2194678A1 Use of muramyl peptide compounds |
| 01/25/1996 | CA2194586A1 Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin |
| 01/25/1996 | CA2194565A1 Anti-helicobacter urea and thiourea derivatives of azolones |
| 01/25/1996 | CA2194563A1 Anti-helicobacter heterocyclic derivatives of azolones |
| 01/25/1996 | CA2194562A1 Sulfonamide derivatives of azolones anti-helicobacter agents |
| 01/25/1996 | CA2194560A1 Cascade-polymer complexes and methods of producing the same |
| 01/25/1996 | CA2194447A1 Recombinant kat enzyme and process for its preparation |
| 01/25/1996 | CA2194374A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension |
| 01/25/1996 | CA2194366A1 A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders |
| 01/25/1996 | CA2193992A1 New pharmaceutical preparation for pain management |
| 01/25/1996 | CA2193681A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
| 01/25/1996 | CA2193490A1 Anti-helicobacter acyl derivatives of azolones |
| 01/25/1996 | CA2188680A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/25/1996 | CA2188451A1 Hydromorphone therapy |
| 01/25/1996 | CA2170526A1 New beads for controlled release and a pharmaceutical preparation containing the same |
| 01/25/1996 | CA2169470A1 New formulation for the topical treatment of psoriasis |
| 01/24/1996 | EP0693558A1 Trehalose and its production and use |
| 01/24/1996 | EP0693498A1 Antiviral compounds |
| 01/24/1996 | EP0693496A1 Novel cephalosporins having a substituted benzyloxyimino radical in position 7, process for their preparation and their use as medicaments |
| 01/24/1996 | EP0693491A1 Oxazolidinones substituted by 5-membered heteroaryl group as antibacterial medicine |
| 01/24/1996 | EP0693489A1 Heterocyclic tachykinin receptor antagonists |
| 01/24/1996 | EP0693481A1 Prodrugs of 5,5-diphenylhydantoin as antiepileptic and antiarrhythmic agents |
| 01/24/1996 | EP0693479A1 Novel aconitine-like compound and antipyretic analgesic anti-inflammatory agent |
| 01/24/1996 | EP0693475A1 1-Phenyl-3-dimethylamino-propane derivatives having pharmacological activity |
| 01/24/1996 | EP0693474A1 Novel benzylaminoethoxybenzene derivative, process for producing the same, and use thereof |
| 01/24/1996 | EP0693471A1 Benzylidene-norcamphor derivatives |
| 01/24/1996 | EP0693287A1 RNA cleaving or binding oligonucleotides |
| 01/24/1996 | EP0693285A2 Pharmaceutical compositions containing a bisphosphonate and an anti-resorptive agent for inhibiting bone loss |
| 01/24/1996 | EP0693284A1 Prostacyclin-containing oleaginous ointment |
| 01/24/1996 | EP0693283A1 Heart failure remedy |
| 01/24/1996 | EP0693282A2 Duloxetine enteric pellets |
| 01/24/1996 | EP0693281A2 Fluoxetine Pharmaceutical formulations |
| 01/24/1996 | EP0693278A2 Combinations of vasoactive substances with fatty acids to prevent hair loss |
| 01/24/1996 | EP0693130A1 Targeted delivery of genes encoding antisense polyribonucleotides |
| 01/24/1996 | EP0693129A1 Method of inhibiting the transcription of genes |
| 01/24/1996 | EP0693123A1 Modified oligonucleotides having improved anti-influenza activity |
| 01/24/1996 | EP0693120A1 Tumoricide t lymphocytes |
| 01/24/1996 | EP0693080A1 New glucocorticoids |
| 01/24/1996 | EP0693079A1 Derivatives of triterpenoid acids and uses thereof |
| 01/24/1996 | EP0693077A1 Antiviral compounds |
| 01/24/1996 | EP0693073A1 Bicyclic ansamycins and their use as antitumor agents |
| 01/24/1996 | EP0693071A1 New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use |
| 01/24/1996 | EP0693070A1 PYRIDO 2,3-b] 1,4]BENZODIAZEPINONES AS M 2? RECEPTOR LIGAND FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| 01/24/1996 | EP0693069A1 Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancer useful in the treatment of cognitive disorders |
| 01/24/1996 | EP0693068A1 Phenylpyrrole derivatives and their use as antipsychotic agents |
| 01/24/1996 | EP0693067A1 Fibrinogen receptor antagonists |
| 01/24/1996 | EP0693062A1 Heterocyclic derivatives in the treatment of ischaemia and related diseases |
| 01/24/1996 | EP0693059A1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 01/24/1996 | EP0693054A1 Cycloalkylhydroxyureas and their use as lipoxygenase inhibitors |
| 01/24/1996 | EP0693053A1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 01/24/1996 | EP0693051A1 Cyclopentene derivatives as endothelin receptor antagonists |
| 01/24/1996 | EP0692972A1 Method for delivering beneficial compositions to hair follicles |
| 01/24/1996 | EP0692968A1 Urokinase plasminogen activator fragments |
| 01/24/1996 | EP0692965A1 Method and composition for treatment of osteoporosis |
| 01/24/1996 | EP0692964A1 Ionene polymers as anthelmintics in animals |
| 01/24/1996 | EP0692963A1 Use of terbinafine for the therapeutic treatment of pneumocystosis |
| 01/24/1996 | EP0692962A1 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses |
| 01/24/1996 | EP0692961A1 Method of producing liposomes |
| 01/24/1996 | EP0692931A1 Synthetic matrix metalloprotease inhibitors and uses thereof |
| 01/24/1996 | EP0692930A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 01/24/1996 | EP0663830A4 Method of treating lung disease with uridine triphosphates. |
| 01/24/1996 | EP0610334B1 Nonpeptidyl integrin inhibitors having specificity for the gpii b iii a receptor |
| 01/24/1996 | EP0579622B1 New phenol ethers, process for producing the same and medicaments containing these compounds |
| 01/24/1996 | EP0576611A4 Radiopharmaceutical agents for the detection of alzheimer's disease |